Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001008161-13-000007
Filing Date
2013-08-02
Accepted
2013-08-02 15:33:13
Documents
1
Period of Report
2013-08-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3830
  Complete submission text file 0001008161-13-000007.txt   5244
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Issuer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address THE ROKEBY BOX 43 3901 W END AVE NASHVILLE TN 37205
Business Address
MITCHELL WILLIAM M (Reporting) CIK: 0001191434 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27072 | Film No.: 131006336